Issue 115, 2015

A novel magnetic drug delivery nanocomplex with a cisplatin-conjugated Fe3O4 core and a PEG-functionalized mesoporous silica shell for enhancing cancer drug delivery efficiency

Abstract

Towards the rapid synthesis and efficient action of a smart drug delivery nanosystem based on coating a layer of PEG functionalized mesoporous silica onto a cisplatin (CDDP) conjugated Fe3O4 nanocomposite. We achieve a number of nanocomplex enhancements of the biomagnetic carriers’ therapeutic functionality. Such a novel drug-delivery nanosystem has potential applications in cancer treatment.

Graphical abstract: A novel magnetic drug delivery nanocomplex with a cisplatin-conjugated Fe3O4 core and a PEG-functionalized mesoporous silica shell for enhancing cancer drug delivery efficiency

Supplementary files

Article information

Article type
Communication
Submitted
18 Sep 2015
Accepted
21 Oct 2015
First published
22 Oct 2015

RSC Adv., 2015,5, 94534-94538

Author version available

A novel magnetic drug delivery nanocomplex with a cisplatin-conjugated Fe3O4 core and a PEG-functionalized mesoporous silica shell for enhancing cancer drug delivery efficiency

C. Rejeeth, R. Vivek and S. Kannan, RSC Adv., 2015, 5, 94534 DOI: 10.1039/C5RA19274A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements